当前位置:主页 > 热门新闻 >
热门新闻
联系我们

WuXi PharmaTech (NYSE: WX) CEO Honored with Ernst & Youn

文章出处:AG88 发表时间:2018-11-02

SHANGHAI, China, Oct. 29 /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYSE: WX), China’s premier provider of pharmaceutical R&D outsourcing services announced today that Dr. Ge Li, the company’s Chairman and Chief Executive Officer received the Ernst & Young Entrepreneur Of The Year (EOY) China 2007 Award. This prestigious award was presented to Dr. Li and 10 other elite entrepreneurs on October 26 in the China World Hotel, Beijing, China.

(Logo: /uploads/allimg/180930/20180930145926phbs4dmsztu41044.jpg )

The Ernst & Young Entrepreneur of the Year Awards China program was founded by Ernst & Young to champion entrepreneurs, whose ideas, vision and energy have prompted profound change in the Chinese economy and who have shown entrepreneurial spirit. This year’s recipients include Charles Zhang, Chairman and CEO of Sohu.com Inc. -- the fourth most popular website in China and 22nd most popular website in the world, and Zhengrong Shi, Chairman and CEO of Suntech Power Holdings Co. Ltd. -- the leading solar energy company in China and the fourth largest solar energy equipment maker in the worlAAAAAAAA> The judges of the selection panel are drawn from those at the forefront of the business and academic communities. According to the panel, winners are selected based on the following criteria: entrepreneurial spirit, corporate financial performance, strategic direction, national or global impact, innovation, and personal integrity and influence.

Dr. Li is honored as the only winner to represent the pharmaceutical sector in China. "He has influenced the way big pharmaceutical companies think about China, and China’s respect for intellectual property," according to Ernst & Young.

"I’m deeply honored to be listed among China’s finest entrepreneurs," commented Dr. Ge Li, Chairman and Chief Executive Officer of WuXi PharmaTech. "I’m very proud to see WuXi PharmaTech’s success recognized by Ernst & Young. Our business has grown in leaps and bounds from an ordinary start-up to an NYSE listed company, but our entrepreneurial spirit has never diminished. This award will spur us on to pursue the highest levels of integrity, quality, and professionalism in providing a full range of sophisticated drug R&D services to our customers."

Winners at the Ernst & Young Entrepreneur of the Year Award China 2007 will join the China EOY Academy, comprising current and past winners from China. All award winners will also be inducted into the World EOY Academy, a global forum.

About The Ernst & Young Entrepreneur Of The Year (EOY) Awards

The Ernst & Young Entrepreneur Of The Year (EOY) Awards program is the world’s most prestigious business accolade for entrepreneurs. Recognized globally, the awards honor the most outstanding entrepreneurs who inspire others with their vision, leadership and achievement. Created in the United States in 1986, the Ernst & Young Entrepreneur of the Year Awards program has now expanded to more than 125 cities in 40 countries, with awards presented to over 900 of the world’s most successful and innovative entrepreneurs.

About Ernst & Young

Ernst & Young is one of the world’s largest professional services firms, it provides clients with assistance in all kind of business issues including audit, tax, corporate finance, transactions, online security, and enterprise risk management. For more information please visit http://www.ey.com .

About WuXi PharmaTech

Founded in 2000, Shanghai-based WuXi PharmaTech is the leading China-based pharmaceutical and biotechnology R&D outsourcing company. As a research- driven and customer-focused company, WuXi PharmaTech provides pharmaceutical and biotechnology companies a broad and integrated portfolio of laboratory and research manufacturing services throughout the drug discovery and development process. WuXi PharmaTech’s services are designed to assist its global partners in shortening the cycle and lowering the cost of drug discovery and development by providing cost-effective and efficient outsourcing solutions that save its customers both time and money. Its operations are grouped into two segments: laboratory services, consisting of discovery chemistry, service biology, analytical, toxicology, pharmaceutical development and process development services, and manufacturing, focusing on manufacturing of advanced intermediates and active pharmaceutical ingredients for R&D use. In 2006, WuXi PharmaTech provided services to 70 pharmaceutical and biotechnology customers, including nine of the top ten pharmaceutical companies in the world, as measured by 2006 total revenues. For more information, please visit: http://www.wuxipharmatech.com .

本文源自: 环亚娱乐